Product Information
OXYBUTYNIN CL ER 10 MG TABLET is a generic product labeled by Amneal Pharmaceuticals LLC, priced at $0.1045 per EA under NDC 65162037210. Its NADAC has been published 509 times since Jan 6, 2016.
FDA first approved this application on Nov 23, 2015. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
Strength
10 mg/1
Manufacturer
Amneal Pharmaceuticals LLCNDC
65162037210
Classification
Generic
Dosage Form
TABLET, EXTENDED RELEASE
Route
ORAL
Effective Date
9/17/2025
Active Ingredients
OXYBUTYNIN CHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204010FDA Approved
11/23/2015
TE Code
AB
On Market Since
11/2/2015
Pharmacological Classes
Price Statistics
The NADAC for OXYBUTYNIN CL ER 10 MG TABLET has been published 509 times since Jan 6, 2016, and over the history we have for it it has declined 87.6%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1045 per EA |
|---|---|
| All-time high | $0.8461 (Jan 13, 2016) |
| All-time low | $0.0837 (Nov 20, 2024) |
| 52-week high | $0.1077 |
| 52-week low | $0.1045 |
| Median price | $0.2273 |
| Average price | $0.3010 |
| Largest weekly change | +35.2% (Jun 19, 2024) |
| Weeks tracked | 509 |
| Tracking since | Jan 6, 2016 |
1W
N/A
1M
N/A
3M
N/A
6M
N/A
1Y
-3.0%
3Y
-8.4%
5Y
-46.1%
All
-87.6%
Last surveyed Oct 1, 2025 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 7 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 6% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of OXYBUTYNIN CL ER 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for OXYBUTYNIN CL ER 10 MG TABLET, manufactured by Amneal Pharmaceuticals LLC, is $0.1045 per EA (NDC 65162037210), effective Oct 1, 2025.
How has the price of OXYBUTYNIN CL ER 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has declined 87.6%. It has been tracked across 509 weekly CMS publications since Jan 6, 2016.
What are the highest and lowest recorded NADAC prices for OXYBUTYNIN CL ER 10 MG TABLET?
Since Jan 6, 2016, the NADAC for OXYBUTYNIN CL ER 10 MG TABLET has ranged from a low of $0.0837 (Nov 20, 2024) to a high of $0.8461 (Jan 13, 2016), with a median of $0.2273 per EA.
Are there cheaper alternatives to OXYBUTYNIN CL ER 10 MG TABLET?
Yes. 7 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, OXYBUTYNIN CL ER 10 MG TABLET, is $0.0978 per EA — about 6% below OXYBUTYNIN CL ER 10 MG TABLET.
Who manufactures OXYBUTYNIN CL ER 10 MG TABLET?
OXYBUTYNIN CL ER 10 MG TABLET (NDC 65162037210) is labeled by Amneal Pharmaceuticals LLC, and CMS classifies it as a generic product.